News
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
6h
Zacks Investment Research on MSNPFE New & Acquired Drugs Back 1H Top-Line Growth: Will the Trend Last?
With the end of the pandemic, sales of Pfizer’s PFE COVID products, Comirnaty and Paxlovid, have declined from their peak.
Merck has begun the 8% reduction of its workforce—an initiative that the company revealed two weeks ago—with the dismissal of ...
Merck’s second quarter performance aligned with Wall Street’s revenue expectations but drew a negative reaction from the ...
Merck & Co., Inc. recently reported robust earnings, yet the market response was lukewarm. Investors overlooked several positive aspects beneath the surface. Unusual expenses, totaling US$4.2 billion, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results